These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12154278)

  • 21. Combination therapy with clopidogrel and aspirin: can the CURE results be extrapolated to cerebrovascula patients?
    Albers GW; Amarenco P
    Stroke; 2001 Dec; 32(12):2948-9. PubMed ID: 11740003
    [No Abstract]   [Full Text] [Related]  

  • 22. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic drugs for secondary stroke prophylaxis--a comment.
    Hansen DB
    Pharmacotherapy; 2001 Aug; 21(8):1020; author reply 1021-2. PubMed ID: 11718493
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiplatelet agents for secondary prevention of ischemic stroke.
    Majid A; Delanty N; Kantor J
    Ann Pharmacother; 2001 Oct; 35(10):1241-7. PubMed ID: 11675854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of ischaemic stroke--antiplatelets.
    McCabe DJ; Brown MM
    Br Med Bull; 2000; 56(2):510-25. PubMed ID: 11092100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What's new in stroke? The top 10 studies of 2006-2008. Part I.
    Hart RG
    Pol Arch Med Wewn; 2008 Nov; 118(11):650-7. PubMed ID: 19140569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antiplatelet therapy of secondary stroke prevention after ESPS-2 and CAPRIE].
    Alvarez-Sabín J; Montaner-Villalonga J
    Rev Neurol; 1999 Oct 16-31; 29(8):780-4. PubMed ID: 10560115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Platelet-function inhibitors in the secondary prevention of ischemic stroke].
    Busse O; Diener HC; Grond M
    Dtsch Med Wochenschr; 2006 Nov; 131 Suppl 5():S132-4. PubMed ID: 17089258
    [No Abstract]   [Full Text] [Related]  

  • 29. [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
    Diener C
    MMW Fortschr Med; 2008 May; 150(21):7. PubMed ID: 18578065
    [No Abstract]   [Full Text] [Related]  

  • 30. [ASS plus dipyridamole or clopidogrel after stroke: what is the best secondary prevention?].
    Einecke D
    MMW Fortschr Med; 2008 May; 150(21):6-7. PubMed ID: 18575244
    [No Abstract]   [Full Text] [Related]  

  • 31. The approach to optimizing stroke care.
    Panagos PD
    Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiplatelet agents. European perspective.
    Sivenius J; Kaste M
    Adv Neurol; 2003; 92():293-9; discussion 301-5. PubMed ID: 12760196
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?
    Amarenco P; Donnan GA
    Stroke; 2004 Nov; 35(11):2606-8. PubMed ID: 15472090
    [No Abstract]   [Full Text] [Related]  

  • 35. [Recurrence prophylaxis for stroke patients. Which platelet inhibitor combination protects best?].
    MMW Fortschr Med; 2003 Jul; 145(29-30):63. PubMed ID: 12958789
    [No Abstract]   [Full Text] [Related]  

  • 36. Growth in clopidogrel-aspirin combination therapy.
    Brinker AD; Swartz L
    Ann Pharmacother; 2006 Jun; 40(6):1212-3. PubMed ID: 16684805
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease.
    Harbison JW
    Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S17-20. PubMed ID: 9784798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet therapy in stroke prevention: present and future.
    Caplan LR
    Cerebrovasc Dis; 2006; 21 Suppl 1():1-6. PubMed ID: 16479096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials.
    Hankey GJ; Sudlow CL; Dunbabin DW
    Stroke; 2000 Jul; 31(7):1779-84. PubMed ID: 10884487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.